Jiangsu Zhongbang Passed Telmisartan WC Audit By Jiangsu Province Authority

Apr.04,2016

The certification audit group from Jiangsu Food and Drug Administration has audited Jiangsu Zhongbang Pharma from 2016.03.30-2016.04.01.

During the two-and-half-day audit, the certification audit group conducted a thorough spot inspection on the factory for Esomeprazole Sodium in strict accordance with EU regulations, which includes Quality Management, Organization and Personnel, Plant and Facilities, Equipment, Validation and Confirmation, File Management, Quality Control, Quality Assurance and other aspects. As a result, the authority made a comprehensive assessment that Jiangsu Zhongbang Pharma"s Esomeprazole Sodium complies with the EU requirements.

This event marks a new stage of the company's quality management level and product quality, laying a solid foundation for the company’s healthy and sustainable development.On behalf of all staff, the general manager Mr. Xu expressed his sincere thanks to the certification audit group, and said that the company will continue to enhance the level of GMP management and strive to achieve the goal of entering standard drug market.